@inproceedings{inproceedings, title  = {{Abstract CT330: Adjusting for confounding effects of treatment crossover in a randomized phase 2 study of dabrafenib plus trametinib inBRAFV600+ metastatic melanoma}},

 publisher = {{American Association for Cancer Research}},

 url = {{}},

 year = {{2014}},

 month = {{10}},

 author = {{Latimer N and Amonkar M and Stapelkamp C and Sun P}},

 doi = {{10.1158/1538-7445.am2014-ct330}},

 journal = {{Clinical Trials}},

 note = {{Accessed on 2024/12/22}}}